HOME >> BIOLOGY >> NEWS
UT Southwestern researchers uncover gene variant that appears to predict type 2 diabetes

s overweight.

Certain ethnic populations appear to have a higher risk of developing type 2 diabetes, whether overweight or not, particularly South Asians people originating from India, Pakistan and Bangladesh.

The study focused on 679 South Asians living in Chennai, India (of which 223 had type 2 diabetes); 1,083 South Asians living in Dallas who were new immigrants or first-generation immigrants from India, Pakistan or Bangladesh (of which 121 had type 2 diabetes); and 858 nonmigrant Caucasians living in Dallas (of which 141 were type 2 diabetics). All study participants with type 2 diabetes were required to have had diabetes onset before age 60.

All subjects were evaluated for diabetes and family history of diabetes, as well as overall general health, and had blood tests conducted for genetic sampling.

Results showed the presence of the ENPP1 variant in 25 percent of the nondiabetic group and in 34 percent of the diabetic group of South Asians living in India; in 33 percent and 45 percent, respectively, in the nondiabetic and diabetic South Asians in Dallas; and 26 percent and 39 percent, respectively, in the nondiabetic and diabetic Caucasians. The gene ENPP1 encodes a protein that blocks the action of insulin. The genetic variation increases the action of this protein and blocks insulin action even more.

"Earlier studies we conducted showed a propensity toward insulin resistance and type 2 diabetes in South Asians, even when they were thin," Dr. Abate said. "This study expanded that to include diabetic patients and Caucasians of European descent. It also took into account the possible influence of environmental factors by comparing South Asians in both Dallas and in Chennai.

"Consistently, we found that this gene variant in all three groups predicted diabetes."

UT Southwestern researchers plan to expand their studies to other ethnic populations, as well as further examine the specific protein involved, with the hope of eventu
'"/>

Contact: Donna Steph Hansard
donna.hansard@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
25-Mar-2005


Page: 1 2 3

Related biology news :

1. UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
2. UT Southwestern leaders to receive national award for medical research accomplishments
3. UT Southwestern scientist receives NIH Directors Pioneer Award
4. UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research
5. UT Southwestern researchers find gene mutation that leads to broken hearts
6. Plague agent helps UT Southwestern researchers find novel signaling system in cells
7. One of the nations first 7-Tesla magnetic resonance imaging devices for human studies planned at UT Southwestern Medical Center
8. DNA end caps may lead to cancer treatments, UT Southwestern researchers report
9. UT Southwestern scientist honored among best in Texas research
10. UT Southwestern scientist receives international award for pediatric research
11. UT Southwestern physician-researcher wins international award for lipid research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 21, 2020 , ... Worcester Polytechnic Institute (WPI) is expanding an existing ... to address the expected spike of COVID-19 cases. As part of its longtime Math ... 3D printers and other materials to be sent to six countries to facilitate the ...
(Date:4/18/2020)... , ... April 17, 2020 ... ... miniature lab device that uses magnetic nano-beads to isolate minute bacterial particles ... strains of bacterial infections and difficult-to-detect micro-particles such as those making up ...
(Date:4/16/2020)... ... 15, 2020 , ... RoosterBio Inc., a leading supplier of ... that the Medical Technology Enterprise Consortium (MTEC) recognized a multi-institution team with a ... The Regenerative Medicine (RegenMed) biomanufacturing collaboration had created a team initiative led by ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell ... will continue to lead Sentien’s Board of Directors, a role he has filled for ... Sentien’s management team. , Mr. Ganz has more than 30 years of ...
(Date:5/14/2020)... ... May 13, 2020 , ... Early stages of drug ... or no information on the drug’s mechanism of action (MOA). Gene expression profiling ... measuring the activity of molecular pathways. This information can complement phenotypic readouts and ...
(Date:5/5/2020)... Fla. (PRWEB) , ... May 05, 2020 , ... ... and solutions company, announced today the launch of its iGlucose® LTE ... new iGlucose solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular ...
(Date:4/22/2020)... , ... April 20, 2020 , ... ... in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila Berces ... Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role ...
Breaking Biology Technology:
Cached News: